Clinical efficacy and changes in the dosages of concomitantly used psychotropic drugs in memantine therapy in Alzheimer's disease with behavioral and psychological symptoms on dementia

Therapeutic Advances in Psychopharmacology

Volumn 3, Issue 3, 2013, Pages 123-128

  Suzuki, Hidenobu ^a   Inoue, Yuichi ^b   Nishiyama, Akiyoshi ^c   Mikami, Katsunaka ^d   Gen, Keishi ^e  

^a Tanzawa Hospital   (Japan)

^b Shakomae Kokorono Clinic   (Japan)

^c TOKAI UNIVERSITY HACHIOJI HOSPITAL   (Japan)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e Seimo Hospital KG   (Japan)

Author keywords

Alzheimer's disease; behavioral and psychological symptoms on dementia; memantine; psychotropic drugs

Indexed keywords

DIAZEPAM; MEMANTINE; RISPERIDONE; VALPROIC ACID;

ADD ON THERAPY; AGED; AGITATION; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; COGNITION; CONTROLLED STUDY; DELUSION; DEMENTIA; DRUG DOSE INCREASE; DRUG EFFICACY; DSM-IV; FEMALE; HALLUCINATION; HOSPITAL PATIENT; HUMAN; IRRITABILITY; LOCOMOTION; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHIATRIC INVENTORY; PRIORITY JOURNAL;

EID: 84997908249     PISSN: 20451253     EISSN: 20451261     Source Type: Journal    
DOI: 10.1177/2045125312471666     Document Type: Article

References (17)

1. Clerici F. Vanacore N. Elia A. et al. (2011) Memantine Lombardy Study Group. Memantine effects on behaviour in moderately severe to severe Alzheimer's disease: a post-marketing surveillance study. Neurol Sci 33: 23–31.
2. Cummings J. Mega M. Gray K. Rosenberg-Thompson S. Carusi D. Gornbein J. (1994) The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44: 2308–2314.
3. Cummings J. Schneider E. Tariot P. Graham S. (2006) Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment. Neurology 67: 57–63.
4. Drimer T. Shahal B. Barak Y. (2004) Effects of discontinuation of long-term anticholinergic treatment in elderly schizophrenia patients. Int Clin Psychopharmacol 19: 27–29.
5. Finkel S. Costa E. Silva J. Cohen G. Miller S. Sartorius N. (1996) Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr 8: 497–500.
6. Folstein M. Folstein S. McHugh P. (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–198.
7. Gauthier S. Loft H. Cummings J. (2008) Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis. Int J Geriatr Psychiatry 23: 537–545.
8. Inagaki A. Inada T. (2006) Dose equivalence of psychotropic drugs. Part XVIII: dose equivalence of psychotropic drugs. Jpn J Psychopharmacol 9: 1443–1447 (in Japanese).
9. Inagaki A. Inada T. (2012) Dose equivalence of psychotropic drugs. Part XXIII: dose equivalence of novel antipsychotics. Jpn J Psychopharmacol 15: 397–404 (in Japanese).
10. Inoue Y. Suzuki H. Otomo M. Gen K. (2011) Study of the efficacy and safety of risperidone long acting injection in elderly schizophrenia patients. Jpn J New Clin 60: 109–116 (in Japanese).
11. Kudo T. (2012) The effect of memantine on BPSD. Jpn J Psychopharmacol 15: 53–58 (in Japanese).
12. McKhann G. Drachman D. Folstein M. Katzman R. Price D. Stadlan E. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939–944.
13. Meltzer H. Casey D. Garver D. Marder S. Masand P. Miller D. (1998) Evaluating the effects of antipsychotics on cognition in schizophrenia. J Clin Psychiatry 59(Suppl. 12): 35–40.
14. Obeso J. Martinez-Lage J. (1987) Anticholinergics and amantadine. In: Koller W. (ed.), Handbook of Parkinson's Disease. New York: Marcel Dekker, pp. 309–316.
15. Reisberg B. Doody R. Stöffler A. Schmitt F. Ferris S. Möbius H. (2003) Memantine Study Group. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 348: 1333–1341.
16. Stewart S. (2005) The effects of benzodiazepines on cognition. J Clin Psychiatry 66: 9–13.
17. Tariot P. Farlow M. Grossberg G. Graham S. McDonald S. Gergel I. for the Memantine Study Group (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 291: 317–324.